Gilead Sciences (GILD)
$66.70
0.11 (0.17%)
GILD Stock Quote Delayed 30 Minutes
3 Deep Value Stocks for Income and High Total Returns
Look to these value stocks for a great blend of dividend safety, payout growth, current yield and capital appreciation potential.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
83.63B
PE Ratio
190.57
EPS
0.35
Volume (Avg. Vol.)
4.21M
Day's Range
$66.01 - $66.93
52-Week Range
$62.07 - $87.86
Dividend & Yield
$3.00 (4.50%)
GILD Stock Predictions, Articles, and Gilead Sciences News
Which Biotech Stocks Are a Buy on Earnings?
If you’re interested in high-growth biotech stocks with superior fundamentals, here are which ones to consider, and which ones to skip.
4 Top Stock Trades for Monday: TWLO, SNAP, SPAQ, GILD
Twilio, Gilead Sciences, Snap and Spartan Energy Acquisition are our top stock trades to watch on Monday. And here's why.
Gilead Stock: 12 Things for Investors to Know About Remdesivir Approval
Want to know what the big remdesivir approval actually means for Gilead stock? Here's everything investors need to understand.
GILD News: Gilead Stock Pops as FDA Approves Remdesivir Treatment
Gilead stock is climbing higher Thursday after its remdesivir coronavirus treatment received full approval from the FDA. Why it matters.
5 Top Stock Trades for Friday: PINS, CROX, STZ, CAG, GILD
Pinterest, Crocs, Gilead Sciences, Constellation Brands and ConAgra Foods were our top stock trades from Thursday.
Merger Mania: 4 Major Deals to Watch
It’s an exciting time for mergers and acquisitions in some of the hottest sectors -- including software, cloud services, artificial intelligence and health care. Here are four major mergers to watch.
Immunomedics News: IMMU Stock Skyrockets 99% on Gilead Deal
Immunomedics (IMMU) is seeing IMMU stock soar higher Monday following news that it will be acquired by Gilead (GILD) for $21 billion.
What Happened to Gilead Sciences and Is the Stock Still a Buy?
Gilead stock has been under pressure for a few months, giving investors a great risk/reward setup, especially with its coronavirus treatment.
Remdesivir Data Leaves Gilead Stock Well-Positioned to Rally
Strong sales of Gilead's successful novel coronavirus drug, remdesivir, will ultimately lift GILD stock and reward shareholders.
Quick Income from a Put Write on Johnson & Johnson
Earnings season is upon us, and Johnson & Johnson (NYSE:JNJ) will kick off second-quarter reporting for the big pharmaceutical stocks on July 16.
